Evidence map›Paper›PMID 37926452›Full record

ArticleSaudi medical journal2023

Prevalence of stroke among patients with chronic kidney disease, Taif, Saudi Arabia.

Adnan A Mubaraki, Waad D Alotaibi, Afnan K Sibyani, Ghaida T Alrbaiai, Haneen S Almalki, Hashim M Atallah, Abdullah S Basfar, Asrar Alqaedi, Hisham A Althobaiti, Mohammed M Algethami and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Adnan A MubarakiFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
Waad D AlotaibiFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0001-8596-3452
Afnan K SibyaniFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
Ghaida T AlrbaiaiFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
Haneen S AlmalkiFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
Hashim M AtallahFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
Abdullah S BasfarFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
Asrar AlqaediFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
Hisham A AlthobaitiFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
Mohammed M AlgethamiFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
Youssef A AlthobaitiFrom the Department of Medicine (Mubaraki); from the College of Medicine (Atallah, Basfar), Taif University, from the Department of Internal Medicine (Alotaibi), King Abdulaziz Specialist Hospital; from the Department of Medicine (Y. A. Althobaiti), King Abdulaziz Specialist Hospital, from the Department of Nephrology (Alqaedi), Taif Children Hospital, from the Department of Medicine (H. A. Althobaiti), King Faisal Medical Complex, from the Department of Medicine (Algethami), Alhada Armed Forces Hospital, Taif, from the Department of Neurology (Sibyani), National Guard Health Affairs, from the Department of Neurology (Alrbaiai), King Abdullah Medical Complex, Directorate of Health Affairs, Jeddah, and from the Department of Emergency Medicine (Almalki), Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia.
Taif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the prevalence of stroke among chronic kidney disease (CKD) patients in Taif, Saudi Arabia.

methodsA multicentric retrospective study was carried out from May 2021 to August 2022 on 4 dialysis centers in Taif, Saudi Arabia. With a total of 1857 CKD patients (aged ≥18 years old) participated in this study. Data were collected by reviewing patients' files.

resultsApproximately 98.3% of the participants had severely decreased glomerular filtration rate. Approximately 49.1% of them were on dialysis; the majority of them (87.2%) underwent hemodialysis. The prevalence of stroke in these CKD patients was 8.3%. Ischemic stroke was the most frequently reported issue (81.2%). Ischemic stroke was comparatively more frequently observed in peritoneal dialysis patients (12.1%); whereas hemorrhagic stroke was more on hemodialysis patients with statistically significant association (

conclusionThe prevalence of stroke in our cohort was 8.3%, and the majority of cases were ischemic strokes. Furthermore, ischemic strokes were more frequent in peritoneal dialysis patients, whereas hemorrhagic strokes occurred more frequently in hemodialysis patients with a statistically significant association.

Indexed as

Ischemic StrokeKidney Failure, ChronicRenal Insufficiency, ChronicStrokeAdolescentAdultGlomerular Filtration RateHumansPrevalenceRenal DialysisRetrospective StudiesSaudi Arabiacerebrovascular diseasechronic kidney diseaseend-stage renal diseaseglomerular filtrationprevalencerenal failurestroke

Identifiers

PMID37926452
PMCPMC10712769
OpenAlexW4388385584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.